David Southern, managing director at Spirit Access, outlines the pathway to value and explains why he believes that commercial models of UK pharma companies need to change.
University Hospitals of Leicester (UHL) NHS Trust was facing major challenges with its ophthalmology services. Just like many other UK Trusts, its teams were working at near capacity but, as patient demand continued to grow, resources were becoming increasingly stretched.
The escalating demand was placing particular pressure on cataract services, where processes and systems were still based on an old model that had been built to support lower volumes of patients. The Trust recognised that its cataract pathway needed to be much more efficient.
Subsequent efforts to redesign the pathway using discrete event simulation to plan and predict demand, and effective implementation techniques, have helped UHL increase the capacity and throughput of its cataract services without the need for additional resource. It is anticipated that the new pathway will enable the Trust to treat almost 1200 extra patients each year, increasing its income without incurring further costs.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
